These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32817362)

  • 1. Passport to freedom? Immunity passports for COVID-19.
    Brown RCH; Savulescu J; Williams B; Wilkinson D
    J Med Ethics; 2020 Oct; 46(10):652-659. PubMed ID: 32817362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.
    Voo TC; Clapham H; Tam CC
    J Infect Dis; 2020 Aug; 222(5):715-718. PubMed ID: 32582943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Immunity Passport to Ease Travel Restrictions?
    Chen LH; Freedman DO; Visser LG
    J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32463093
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges.
    Phelan AL
    Lancet; 2020 May; 395(10237):1595-1598. PubMed ID: 32380041
    [No Abstract]   [Full Text] [Related]  

  • 5. The COVID-19 Pandemic: Ethical and Scientific Imperatives for "Natural" Experiments.
    Erren TC; Lewis P; Shaw DM
    Circulation; 2020 Jul; 142(4):309-311. PubMed ID: 32441996
    [No Abstract]   [Full Text] [Related]  

  • 6. The false promise of herd immunity for COVID-19.
    Aschwanden C
    Nature; 2020 Nov; 587(7832):26-28. PubMed ID: 33087872
    [No Abstract]   [Full Text] [Related]  

  • 7. Full Throttle: COVID-19 Open Science to Build Planetary Public Goods.
    Von Schomberg R; Özdemir V
    OMICS; 2020 Sep; 24(9):509-511. PubMed ID: 32628565
    [No Abstract]   [Full Text] [Related]  

  • 8. Papers Please - Predictive Factors of National and International Attitudes Toward Immunity and Vaccination Passports: Online Representative Surveys.
    Garrett PM; White JP; Dennis S; Lewandowsky S; Yang CT; Okan Y; Perfors A; Little DR; Kozyreva A; Lorenz-Spreen P; Kusumi T; Kashima Y
    JMIR Public Health Surveill; 2022 Jul; 8(7):e32969. PubMed ID: 35377317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a Public Health Ethics Framework to Unpick Discrimination in COVID-19 Responses.
    Chung RY; Erler A; Li HL; Au D
    Am J Bioeth; 2020 Jul; 20(7):114-116. PubMed ID: 32716797
    [No Abstract]   [Full Text] [Related]  

  • 10. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
    Goudsmit J
    Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914
    [No Abstract]   [Full Text] [Related]  

  • 11. 'Immunity Passports' for SARS-CoV-2: an online experimental study of the impact of antibody test terminology on perceived risk and behaviour.
    Waller J; Rubin GJ; Potts HWW; Mottershaw AL; Marteau TM
    BMJ Open; 2020 Aug; 10(8):e040448. PubMed ID: 32868370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 13. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?
    Laxminarayan R; John TJ
    Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative strategic approaches to COVID-19 in Africa: Balancing public interest with civil liberties.
    Obasa AE; Singh S; Chivunze E; Burgess T; Masiye F; Mtande T; Ochieng J; Chalwe V; Mokgatla B; Rennie S; Moodley K
    S Afr Med J; 2020 Aug; 110(9):858-863. PubMed ID: 32880268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity certification for COVID-19: ethical considerations.
    Voo TC; Reis AA; Thomé B; Ho CW; Tam CC; Kelly-Cirino C; Emanuel E; Beca JP; Littler K; Smith MJ; Parker M; Kass N; Gobat N; Lei R; Upshur R; Hurst S; Munsaka S
    Bull World Health Organ; 2021 Feb; 99(2):155-161. PubMed ID: 33551509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2: a time for clear and immediate action.
    Poland GA
    Lancet Infect Dis; 2020 May; 20(5):531-532. PubMed ID: 32243818
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ethical dimensions of prevention and planning in assisted-living facilities during the SARS-CoV-2 pandemic (Covid-19): a public health emergency.].
    Coronado-Vázquez V; Castro-Martín J; Cámara-Escribano C; Gómez-Salgado J; Martín-López C; García-Iglesias JJ
    Rev Esp Salud Publica; 2020 Sep; 94():. PubMed ID: 32894259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    Kwok KO; Lai F; Wei WI; Wong SYS; Tang JWT
    J Infect; 2020 Jun; 80(6):e32-e33. PubMed ID: 32209383
    [No Abstract]   [Full Text] [Related]  

  • 19. Herd immunity and COVID-19.
    Chen J; Ye L; Zhou MY; Cheng YR; Wang MW; Feng ZH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4064-4065. PubMed ID: 32374011
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19-a very visible pandemic.
    Durrheim DN; Baker MG
    Lancet; 2020 Aug; 396(10248):e17. PubMed ID: 32771112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.